231.01

1.36% -3.18

After Hours: 233.00 1.99 +0.86%

Inspire Medical Systems Inc (INSP)

Overview News Price History Option Chain Why INSP Down? Discussions Forecast

Inspire Medical Systems Inc stock is currently priced at $231.01, with a 24-hour trading volume of 215.36K. It has seen a -1.36% decreased in the last 24 hours and a +12.60% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $234.7 pivot point. If it approaches the $230.4 support level, significant changes may occur.

Previous Close:

$234.19

Open:

$231.41

24h Volume:

215.36K

Market Cap:

$7.00B

Revenue:

$624.80M

Net Income/Loss:

$-21.15M

P/E Ratio:

-160.42

EPS:

-1.44

Net Cash Flow:

$1.02M

1W Performance:

-4.20%

1M Performance:

+12.60%

6M Performance:

+52.38%

1Y Performance:

-13.32%

1D Range:

$224.06

$231.68

52W Range:

$123.27

$330.00

Inspire Medical Systems Inc Stock (INSP) Company Profile

Name

Inspire Medical Systems Inc

Sector

Healthcare (1197)

Industry

Medical Devices (158)

Phone

844-672-4357

Address

9700 63rd Avenue North, Suite 200, Maple Grove

Employee

150

Twitter

@inspiresleep

Next Earnings Date

2024-05-07

Latest SEC Filings

INSP's Discussions on Twitter

Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight
Jan-19-24	Initiated	Jefferies	Buy
Jan-02-24	Downgrade	Stifel	Buy → Hold
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Apr-14-23	Initiated	Mizuho	Buy
Mar-29-23	Initiated	UBS	Buy
Dec-13-22	Upgrade	Goldman	Neutral → Buy
Dec-13-22	Initiated	KeyBanc Capital Markets	Overweight
Apr-13-22	Initiated	Truist	Buy
Apr-06-22	Initiated	Wolfe Research	Peer Perform
Mar-02-22	Resumed	BofA Securities	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Nov-03-20	Upgrade	BofA Securities	Neutral → Buy
Nov-03-20	Upgrade	Oppenheimer	Underperform → Perform
Sep-22-20	Initiated	JP Morgan	Overweight
Sep-02-20	Initiated	Robert W. Baird	Outperform
Aug-06-20	Downgrade	BofA Securities	Buy → Neutral
Jul-15-20	Initiated	Goldman	Buy
Jun-18-20	Reiterated	Piper Sandler	Overweight
May-18-20	Initiated	Lake Street	Buy
Apr-28-20	Upgrade	BofA/Merrill	Neutral → Buy
Apr-09-20	Initiated	Piper Sandler	Overweight
Jan-28-20	Initiated	Oppenheimer	Underperform
Jan-27-20	Initiated	Oppenheimer	Underperform
Nov-06-19	Upgrade	Berenberg	Sell → Hold
Feb-05-19	Initiated	Dougherty & Company	Buy
Nov-28-18	Initiated	Berenberg	Sell
Oct-29-18	Initiated	Leerink Partners	Outperform
May-29-18	Initiated	Guggenheim	Buy
May-29-18	Initiated	Stifel	Buy
May-29-18	Initiated	Wells Fargo	Outperform

View All

Inspire Medical Systems Inc Stock (INSP) Latest News

Inspire Medical Systems Inc Stock (INSP) Financials Data

Inspire Medical Systems Inc (INSP) Revenue 2024

INSP reported a revenue (TTM) of $624.80 million for the quarter ending December 31, 2023, a +53.19% rise year-over-year.

Inspire Medical Systems Inc (INSP) Net Income 2024

INSP net income (TTM) was -$21.15 million for the quarter ending December 31, 2023, a +52.87% increase year-over-year.

Inspire Medical Systems Inc (INSP) Cash Flow 2024

INSP recorded a free cash flow (TTM) of $1.02 million for the quarter ending December 31, 2023, a -58.59% decrease year-over-year.

Inspire Medical Systems Inc (INSP) Earnings per Share 2024

INSP earnings per share (TTM) was -$0.74 for the quarter ending December 31, 2023, a +54.88% growth year-over-year.

Inspire Medical Systems Inc Stock (INSP) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Buchholz Richard	Chief Financial Officer	Apr 17 '24	Sale	230.03	15,000	3,450,450	28,271
NELSON MARILYN C	Director	Apr 01 '24	Option Exercise	16.00	3,273	52,368	34,338
Griffin Jerry C	Director	Apr 01 '24	Option Exercise	16.00	296	4,736	10,932
Herbert Timothy P.	CEO and President	Apr 01 '24	Sale	205.09	40,000	8,203,581	63,658
Griffin Jerry C	Director	Apr 01 '24	Sale	213.99	32	6,848	10,900
NELSON MARILYN C	Director	Mar 27 '24	Option Exercise	90.85	3,243	294,633	31,065
Griffin Jerry C	Director	Mar 25 '24	Option Exercise	16.00	1,000	16,000	11,190
Griffin Jerry C	Director	Mar 25 '24	Sale	197.81	554	109,587	10,636
Rondoni John	Chief Technology Officer	Mar 22 '24	Sale	194.40	4,387	852,849	11,270
Griffin Jerry C	Director	Mar 18 '24	Option Exercise	16.00	1,000	16,000	10,744

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.